https://charts.traderzeitung.de/phases/US6402683063
string(1454) "{"isin":"US6402683063","name":"Nektar Therapeutics","stock_id_xnas":7874507,"stock_id_xnys":null,"generated_at":"2026-07-20 11:59:00","days":[{"date":"2026-07-15","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":68.17,"close_at":"2026-07-15 10:24:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":68.3,"close_at":"2026-07-15 21:59:00","complete":true,"perf_pct":0.1907},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":68,"close_at":"2026-07-16 15:24:00","complete":true,"perf_pct":-0.4392},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":67.22,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":-1.1471},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":67.12,"close_at":"2026-07-16 22:02:00","complete":true,"perf_pct":-0.1488}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":68.18,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":1.5793},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Nektar Therapeutics Aktie News & Nachrichten

Nektar Therapeutics Aktie News & Nachrichten

[WKN: A419UB | Symbol: NKTR]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Nektar Therapeutics Chart

Artikel aus der Redaktion der Trader-Zeitung

Nektar Therapeutics: Voller Fokus auf den Milliardenmarkt der Immunologie

Nektar Therapeutics verdient sein Geld nicht mit dem eigenen Medikamentenverkauf, sondern durch die...

TOP-5-Kursziele der Analysten am 21.04.26

Uber Technologies [US90353T1007] TD Cowen bestätigt Buy-Rating mit Kursziel 114 USD (47 % Kurspotenzial)...

TOP-5-Kursziele der Analysten am 16.03.26

Rocket Companies [US77311W1018] Keefe Bruyette nimmt Hochstufung von "Market Perform" auf "Outperform"...

TOP-5-Kursziele der Analysten am 11.02.26

Cloudflare [US18915M1071] TD Cowen bekräftigt Buy-Rating mit Kursziel 265 USD (28 % Kurspotenzial)...

  • 1
MT Newswires 22.06.2026 10:10 Uhr

Nektar Therapeutics Insider verkaufte Aktien im Wert von $1.215.056, laut einer aktuellen SEC-Einreichung

04:09 AM EDT, 06/22/2026 (MT Newswires) -- Howard W Robin, Direktor, Präsident & Chief Executive Officer, verkaufte am 16. Juni 2026 20.000 Aktien